In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Brett, covering:
- The complexities of being on the inside of big pharma looking to carve out your site… then transitioning into a customer-facing CDMO
- Leaning into the freedom and liberation of having the shackles off as an independent business
- Pairing world-class, complex commercial capabilities (100 million+ units) with a small scaler clinical offering
- The uncertainty and capacity concerns on the market after that market-shaking deal
- And just why Australia is a hub for global for clinical trials…
Brett Alderson is a seasoned veteran in the pharmaceutical industry predominantly working with the manufacturing of sterile injectables. Brett is a determined and thoughtful leader adept at driving business success and leading through change. He is a champion for customers, instilling a customer-centric culture with transparency and helpfulness.
He enjoys mentoring and nurturing a diverse workforce with a clear imperative of open and honest communication. Brett has a reputation as an energetic problem solver, acting with integrity and care, and always encourages solutions for a brighter tomorrow by empowering people.
Brett’s career includes more than 25 years at Pfizer, before becoming President and Site Leader of Novacina in April 2023 where he oversaw a 500-member team and the production of more than 300 Oncology products plus several additional sterile injectable medicines for local and global markets.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.